Related Experiment Video
Updated: Jun 20, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Ecstasy and dementia in a young subject.
P Granato1, S Weill, J Revillon
1General Psychiatry Department, Valenciennes Hospital, avenue Desandrouin, 59300 Valenciennes, France.
Summary
Ecstasy (MDMA) use can lead to serious cerebrovascular accidents. This case study highlights MDMA-induced frontal dementia in a young adult.
Area of Science:
- Neuroscience
- Toxicology
- Neurology
Background:
- Recreational drug use, including MDMA (Ecstasy), is prevalent among young adults.
- Cerebrovascular events are increasingly recognized as potential complications of stimulant drug use.
- Frontal dementia is a neurodegenerative condition affecting executive functions.
Purpose of the Study:
- To report a rare case of cerebrovascular accident following MDMA intake.
- To describe the subsequent development of frontal dementia in a young patient.
- To emphasize the potential neurological risks associated with MDMA consumption.
Main Methods:
- Case report detailing a young male patient's clinical presentation.
- Review of medical history, neurological examination, and diagnostic imaging.
- Assessment of cognitive function and behavioral changes consistent with frontal dementia.
Main Results:
- The patient experienced a cerebrovascular accident shortly after documented MDMA use.
- Neurological deficits and cognitive impairments indicative of frontal lobe dysfunction were observed.
- Diagnosis of frontal dementia was established, linked temporally to the cerebrovascular event and MDMA intake.
Conclusions:
- MDMA intake can precipitate cerebrovascular accidents with severe neurological sequelae.
- Frontal dementia is a potential, albeit rare, consequence of MDMA-induced neurotoxicity and vascular events.
- Clinicians should consider MDMA use in the differential diagnosis of young individuals presenting with stroke and cognitive decline.
Related Concept Videos
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:27Hallucinogens and Psychedelics
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...